Eucrates Biomedical Acquisition Corp.
EUCR · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | -$0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $1 | $1 | $1 |
| Pre-Tax Income | $0 | $1 | $0 | $1 |
| Tax Expense | -$0 | -$1 | -$0 | -$1 |
| Net Income | $1 | $1 | $1 | $3 |
| % Margin | – | – | – | – |
| EPS | 0.18 | 0.17 | 0.14 | 0.44 |
| % Growth | 5.9% | 21.4% | -68.2% | – |
| EPS Diluted | 0.18 | 0.09 | 0.067 | 0.21 |
| Weighted Avg Shares Out | 3 | 10 | 10 | 3 |
| Weighted Avg Shares Out Dil | 3 | 13 | 13 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | -$0 | -$1 |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |